Binding characterization of N-(2-chloro-5-thiomethylphenyl)- N′-(3-[3H]3 methoxy phenyl)-N′-methylguanidine ([3H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist

被引:3
作者
Metaxas, Athanasios [1 ]
van Berckel, Bart N. M. [1 ]
Klein, Pieter J. [1 ]
Verbeek, Joost [1 ]
Nash, Emily C. [1 ]
Kooijman, Esther J. M. [1 ]
Renjaan, Veronique A. [1 ]
Golla, Sandeep S., V [1 ]
Boellaard, Ronald [1 ]
Christiaans, Johannes A. M. [1 ]
Windhorst, Albert D. [1 ]
Leysen, Josee E. [1 ]
机构
[1] Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, Neurosci Campus Amsterdam, Amsterdam, Netherlands
来源
PHARMACOLOGY RESEARCH & PERSPECTIVES | 2019年 / 7卷 / 01期
关键词
H-3]GMOM; H-3]MK-801; binding; ion-channel; N; '-diaryl-N-methylguanidine; NMDA receptor; CANDIDATE PET TRACER; ION-CHANNEL; IN-VITRO; PRECLINICAL EVALUATION; ANTICONVULSANT MK-801; <H-3>MK-801 BINDING; L-GLUTAMATE; H-3; MK-801; RAT-BRAIN; PCP SITE;
D O I
10.1002/prp2.458
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Labeled with carbon-11, N-(2-chloro-5-thiomethylphenyl)-N'-(3-methoxyphenyl)-N'-methylguanidine ([C-11]GMOM) is currently the only positron emission tomography (PET) tracer that has shown selectivity for the ion-channel site of N-methyl-D-aspartate (NMDA) receptors in human imaging studies. The present study reports on the selectivity profile and in vitro binding properties of GMOM. The compound was screened on a panel of 80 targets, and labeled with tritium ([H-3]GMOM). The binding properties of [H-3]GMOM were compared to those of the reference ion-channel ligand [H-3](+)-dizocilpine maleate ([H-3]MK-801), in a set of concentration-response, homologous and heterologous inhibition, and association kinetics assays, performed with repeatedly washed rat forebrain preparations. GMOM was at least 70-fold more selective for NMDA receptors compared to all other targets examined. In homologous inhibition and concentration-response assays, the binding of [H-3] GMOM was regulated by NMDA receptor agonists, albeit in a less prominent manner compared to [H-3]MK-801. Scatchard transformation of homologous inhibition data produced concave upward curves for [H-3]GMOM and [H-3]MK-801. The radioli-gands showed bi-exponential association kinetics in the presence of 100 mu mot L-1L-glutamate/30 mu mol L-1 glycine. [H-3]GMOM (3 nmol L-1 and 10 nmol L-1) was inhibited with dual affinity by (+)-MK-801, (R,S)-ketamine and memantine, in both presence and absence of agonists. [H-3]MK-801 (2 nmol L-1) was inhibited in a monophasic manner by GMOM under baseline and combined agonist conditions, with an IC50 value of similar to 19 nmol L-1. The non-linear Scatchard plots, biphasic inhibition by open channel blockers, and bi-exponential kinetics of [H-3]GMOM indicate a complex mechanism of interaction with the NMDA receptor ionophore. The implications for quantifying the PET signal of [C-11]GMOM are discussed.
引用
收藏
页数:15
相关论文
共 49 条
[1]   Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias [J].
Ahmed, Imtiaz ;
Bose, Subrata K. ;
Pavese, Nicola ;
Ramlackhansingh, Anil ;
Turkheimer, Federico ;
Hotton, Gary ;
Hammers, Alexander ;
Brooks, David J. .
BRAIN, 2011, 134 :979-986
[2]   Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors [J].
Ametamey, SM ;
Kokic, M ;
Carrey-Rémy, N ;
Bläuenstein, P ;
Willmann, M ;
Bischoff, S ;
Schmutz, M ;
Schubiger, PA ;
Auberson, YP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (01) :75-78
[3]   DIFFERENTIAL MODULATION OF [H-3]TCP BINDING TO THE NMDA RECEPTOR BY L-GLUTAMATE AND GLYCINE [J].
BENAVIDES, J ;
RIVY, JP ;
CARTER, C ;
SCATTON, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (1-2) :67-72
[4]   In vitro and in vivo characterization of [3H]CNS-5161 -: A use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain [J].
Biegon, Anat ;
Gibbs, Andrew ;
Alvarado, Maritza ;
Ono, Michele ;
Taylor, Scott .
SYNAPSE, 2007, 61 (08) :577-586
[5]   DIFFERENT BINDING AFFINITIES OF NMDA RECEPTOR-CHANNEL BLOCKERS IN VARIOUS BRAIN-REGIONS - INDICATION OF NMDA RECEPTOR HETEROGENEITY [J].
BRESINK, I ;
DANYSZ, W ;
PARSONS, CG ;
MUTSCHLER, E .
NEUROPHARMACOLOGY, 1995, 34 (05) :533-540
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[11C]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors [J].
Christiaans, Johannes A. M. ;
Klein, Pieter J. ;
Metaxas, Athanasios ;
Kooijman, Esther J. M. ;
Schuit, Robert C. ;
Leysen, Josee E. ;
Lammertsma, Adriaan A. ;
van Berckel, Bart N. M. ;
Windhorst, Albert D. .
NUCLEAR MEDICINE AND BIOLOGY, 2014, 41 (08) :670-680
[8]   THE NOVEL ANTICONVULSANT MK-801 BINDS TO THE ACTIVATED STATE OF THE N-METHYL-D-ASPARTATE RECEPTOR IN RAT-BRAIN [J].
FOSTER, AC ;
WONG, EHF .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (02) :403-409
[9]  
Fuchigami Takeshi, 2015, ScientificWorldJournal, V2015, P716514, DOI 10.1155/2015/716514
[10]   Preclinical evaluation of [18F]PK-209, a new PET ligand for imaging the ion-channel site of NMDA receptors [J].
Golla, Sandeep S. V. ;
Klein, Pieter J. ;
Bakker, Jaco ;
Schuit, Robert C. ;
Christiaans, Johannes A. M. ;
van Geest, Leo ;
Kooijman, Esther J. M. ;
Oropeza-Seguias, Gisela M. ;
Langermans, Jan A. M. ;
Leysen, Josee E. ;
Boellaard, Ronald ;
Windhorst, Albert D. ;
van Berckel, Bart N. M. ;
Metaxas, Athanasios .
NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (02) :205-212